Service 03

Transaction Support

Buy-side and sell-side support, converting non-consensus opportunities into high-conviction, actionable transactions.

Overview

Sourcing a deal and closing a deal require different skills, and most advisors are only built for one half of that job. Blacklight stays engaged across the full arc: identifying the opportunity, building conviction internally, and driving the transaction through to close.

Whether you're looking to acquire, license, or divest, we bring the market access, analytical rigor, and negotiation experience to convert a non-consensus opportunity into an executed transaction, on either side of the table.

Capabilities

Look to Blacklight for:

Buy-side target sourcing & screening
Sell-side positioning & partner identification
Licensing & partnership structuring
M&A & asset acquisition support
Deal structuring & valuation support
Negotiation strategy & support
Term sheet development
Competitive process management
Closing & transaction execution support
BD strategy & outreach planning
Our Approach

Three steps, one executed transaction.

We stay engaged from the first screen to the signature, so nothing gets lost in a handoff.

01
Source & identify opportunities

Expand beyond the known universe to surface non-obvious acquisition, in-licensing, or partnering candidates, drawing on our proprietary Blacklight Database of epidemiological, clinical, and drug-target information.

02
Evaluate & prioritize

Pressure-test opportunities for strategic fit, transactability, and value on the buy-side, or benchmark positioning and comparables on the sell-side, to focus resources on a high-conviction shortlist.

03
Support through close

Hands-on support through diligence, negotiation, and deal structuring as opportunities advance toward a transaction, on either side of the table.

Case Study

Featured engagement

Exhibit: Featured Engagement
Prioritized In-Licensing Targets Driving BD Focus

Identify and prioritize orphan-disease assets to address an anticipated revenue gap.

Approach
  • Defined transaction-relevant screening criteria aligned to the client's strategic priorities
  • Built and pressure-tested a broad universe of orphan-disease assets against those criteria
  • Narrowed the universe to a focused, high-value shortlist of actionable targets
Result
  • Delivered a prioritized set of actionable BD targets ranked by strategic fit and transactability
  • Accelerated progression to partner discussions on the highest-priority assets
  • Sharpened the client's BD focus around an anticipated revenue gap

Start the conversation.

Tell us about your asset, target, or strategic challenge. We'll follow up within one business day.

Start a Conversation →

We use cookies to run this site and, where enabled, to understand how it's used. See our Privacy Policy for details or manage your choices below.

Cookie Preferences

Choose which categories of cookies you allow. Required cookies are always on because the site cannot function properly without them. See our Privacy Policy for more detail.